SODIUM CHLORIDE (SODIUM CHLORIDE)
Pending LLM rewrite. Source: FDA_DRUG D-0433-2026.
Severity not yet assessed
We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.
Plain-English summary
Lack of Assurance of Sterility
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- Batch# 23SU10001
- Exp Date: 12/31/2026
- Batch# 24AU10003
- 24AU10004
- 24AU10005
- 24AU10008
- Exp Date: 01/31/2027
- Batch # 24EU10001
- 24EU10002
- Exp Date: 05/31/2027
- Batch# 24PU10002
- Exp Date: 11/30/2027
- Batch# 25BU10003
- Exp Date: 02/29/2028
- Batch# 25EU10005
- Exp Date: 05/31/2028.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SODIUM CHLORIDE
- SevereFresenius Sodium Chloride Injection Recall: Lack of Sterility Assurance
FDA (Drugs) · 2025-07-02
- SevereSodium Chloride Injection Recalled for Sterility Assurance Defect
FDA (Drugs) · 2025-07-02
- ModerateSodium Chloride Irrigation Solution Recalled for Particulate Matter
FDA (Drugs) · 2025-04-16
- SevereFDA Class I Recall: B. Braun Sodium Chloride Injection for Particulate Matter
FDA (Drugs) · 2024-08-28
- ModerateIntravenous Sodium Chloride Injection Recalled for Incomplete Labeling and Warnings
FDA (Drugs) · 2023-08-16
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22